Eli Lilly’s weight-loss pill meets target in key diabetes trial

Health

Eli Lilly’s Weight-Loss Pill Meets Target In Key Diabetes Trial

By Financial Times

US pharmaceutical group Eli Lilly has announced that the latest trial of its anti-obesity pill has met weight-loss targets, boosting its plans to seek approval for the drug as it fights for market dominance with rival Novo Nordisk. Lilly said on Tues ...Read more

Related Posts

Jillian Michaels Breaks Silence Netflix Biggest Loser Docuseries

Jillian Michaels Breaks Silence Netflix Biggest Loser Docuseries

Aug 20, 2025
UFC 319 Report: Who can stop Khamzat Chimaev?

UFC 319 Report: Who can stop Khamzat Chimaev?

Aug 18, 2025
Fans call for 'Aljo and Merab hater' Herb Dean to be suspended after controversial refereeing at UFC Shanghai

Fans call for 'Aljo and Merab hater' Herb Dean to be suspended after controversial refereeing at UFC Shanghai

Aug 23, 2025
Buccaneers cut 449-pound Desmond Watson as NFL dream hits major roadblock

Buccaneers cut 449-pound Desmond Watson as NFL dream hits major roadblock

Aug 26, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.